II. Background
- Naturally derived from Coca plant
- South American shrub
- Not the same as the cocoa plant
- Class
- Stimulant
- Local Anesthetic
- Schedule I
III. Preparations
- Formulations (same Cocaine molecule and CNS, cardiovascular effects despite different delivery methods)
- Salt: Fine white powder (blow, coke, snow)
- Snorted or mixed with water and injected
- Base: Crystalline or Rock Crystal (Crack Cocaine)
- Appears similar to soap pieces caked together
- Smoked (vaporizes when heated)
- Second-hand inhalation can effect infants and children
- Salt: Fine white powder (blow, coke, snow)
- Street Names
- Coke
- Snow Flake
- Toot
- Star Dust
- Happy Dust
- Bernice
- Methods of abuse
- Swallowed
- Snorted
- Intravenous
- Freebase residue
- Smoked (solid crack)
IV. Mechanism
- Affects central and peripheral Neurotransmitters (blocks their reuptake)
- Norepinephrine
- Dopamine - arousal
- Serotonin - awakening
-
Class Ib Antiarrhythmic Drug
- Sodium Channel Blocker that shortens Action Potential duration
V. Pharmacokinetics
- Metabolized by serum and hepatic Cholinesterases
- Excreted by Kidneys
- Crosses the placenta by simple diffusion
- Crosses into Breast Milk
- Prolonged Duration and toxicity
- Excessive intake
- "Body Packers" with ruptured bag
- Concurrent Alcohol ingestion
- Excessive intake
- Cocaine (20-300 mg)
- Onset intranasal effects in 1 hour
- Onset faster with intravenous or smoked forms
- Duration: 2-4 hours
- Half life: 90 minutes
- Onset intranasal effects in 1 hour
- Peak Toxicity
- Swallowing: 60-90 minutes
- Snorting: 30-60 minutes
- Intravenous or Smoked: Minutes
VI. Symptoms
- Increased energy and alertness
- Euphoria
- Sociability
- Appetite suppression
- Decreased need for sleep
- Restlessness
- Excitement
VII. Signs: Toxicity (Systemic Sympathomimetic Effect)
- See Cocaine-Induced Coronary Vasospasm
- See Sympathomimetic Toxicity
- Hypertensive
- Sinus Tachycardia (significant)
- Tremors
- Agitation
- Generalized Tonic Clonic Seizures
- Pressured speech
- Diaphoresis
- Contrast with AmitriptylineOverdose which causes dryness (instead of diaphoresis)
VIII. Diagnostics: Electrocardiogram
- QRS Widening
- Sinus Tachycardia
- Paroxysmal Supraventricular Tachycardia and other tachyarrhythmias
IX. Adverse Effects (increased with duration and dose)
- Acute effects
- See Cocaine-Induced Coronary Vasospasm
- See Sympathomimetic Toxicity
- Psychosis (e.g. Hallucinations, paranoia) in 80% of patients
- Aortic Dissection
- Cerebrovascular Accident (both ischemic and Hemorrhagic CVA)
- Hypertension
- Crack Lung (diffuse alveolar injury)
- Tactile Hallucinations (crawling bugs)
- Chronic effects
- Cardiomyopathy
- Perforated nasal septum
- Memory Loss
- Movement Disorders
- Psychiatric disorders
X. Labs
- See Urine Drug Screen
- Detectable in blood, urine, hair, Saliva, sweat, Breast Milk
XI. Management: Toxicity
- See Sympathomimetic Toxicity
- See Cocaine-Induced Coronary Vasospasm
- Avoid Beta Blockers (risk of unopposed alpha-Agonist effect)
- Administer Benzodiazepines
- Preferred agents in Seizures
- Preferred agents in Sympathomimetic Toxicity (Agitation, Hypertension, Tachycardia)
- Treat hyperthermia with cooling
- Evaluate for Dysrhythmia
- Treat Seizures (starting with Benzodiazepines)
XII. Management: Withdrawal
-
Ativan until adequate sedation
- May require significant dosages
-
Propranolol 20 mg qid (indicated for chills)
- Beta Blockers are typically avoided in Cocaine use - theoretical risk of coronary vasospasm
XIII. Management: Abstinence
- Combined group and individual counseling most effective
- Study of effective options for therapy
- Cognitive behavior therapy
- Disulfiram (effective even if no Alcohol Abuse)
- Caroll (2004) Arch Gen Psychiatry 61:264-72 [PubMed]
- Medication therapy
- No medications have been found significantly helpful
- Disulfiram use supported by only low level evidence
- Substitution Therapy (e.g. Ritalin replaces Cocaine) may have benefit (experimental)
XIV. References
- Moore, Behar, Claudius and Farrah in Herbert (2018) EM:Rap 18(5):11-2
- Tagliaferro (2023) Crit Dec Emerg Med 37(1): 21-9
- Klega (2018) Am Fam Physician 98(2): 85-92 [PubMed]
- Shih (1996) Hosp Physician p. 11-20 [PubMed]